ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 084,01
-0,23%
Dow Jones
39 065,26
-1,53%
DAX
18 617,10
-0,37%
Brent Oil
80,55
-0,93%
Bitcoin
67 105,83
-1,20%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Johnson and Johnson (JNJ)

  7. Johnson and Johnson (JNJ) Actualités

JNJ

Johnson and Johnson (JNJ)

Johnson and Johnson
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:JNJ
DateHeureSourceTitreSymboleSociété
22/05/202418h05Business WireProposed Class Action Filed by Six Law Firms Alleging Series of Fraudulent Transfers by Johnson & Johnson in Talc LitigationNYSE:JNJJohnson and Johnson
21/05/202416h43Edgar (US Regulatory)Form CERT - Certification by an exchange approving securities for listingNYSE:JNJJohnson and Johnson
20/05/202423h17Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:JNJJohnson and Johnson
20/05/202422h34Edgar (US Regulatory)Form 8-A12B - Registration of securities [Section 12(b)]NYSE:JNJJohnson and Johnson
20/05/202422h01Edgar (US Regulatory)Form 8-K - Current reportNYSE:JNJJohnson and Johnson
20/05/202415h31Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNYSE:JNJJohnson and Johnson
17/05/202413h36IH Market NewsOpenAI’s Reddit Partnership Boosts Shares by 14%, Microsoft Embraces AMD Chips for AI, and More NewsNYSE:JNJJohnson and Johnson
16/05/202422h16Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:JNJJohnson and Johnson
16/05/202413h30Business WireJohnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis TreatmentNYSE:JNJJohnson and Johnson
14/05/202423h01Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:JNJJohnson and Johnson
14/05/202413h26IH Market NewsWalmart Corporate Job Cuts and Office Centralization, GameStop and AMC Surge, and More NewsNYSE:JNJJohnson and Johnson
14/05/202412h05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:JNJJohnson and Johnson
10/05/202423h14Edgar (US Regulatory)Form 13F-HR - Quarterly report filed by institutional managers, HoldingsNYSE:JNJJohnson and Johnson
08/05/202422h30Business WireJohnson & Johnson to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceNYSE:JNJJohnson and Johnson
06/05/202422h05GlobeNewswire Inc.Shockwave Medical Reports First Quarter 2024 Financial ResultsNYSE:JNJJohnson and Johnson
01/05/202412h30Business WireJohnson & Johnson Announces Plan by its Subsidiary, LLT Management LLC, to Resolve All Current and Future Ovarian Cancer Talc Claims Through a Consensual “Prepackaged” ReorganizationNYSE:JNJJohnson and Johnson
22/04/202422h30Business WireJohnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC)NYSE:JNJJohnson and Johnson
19/04/202413h31IH Market NewsParamount’s Shares Surge Following Sony and Apollo’s Joint Bid; ISS Backs Berkshire Hathaway Director Re-election, and MoreNYSE:JNJJohnson and Johnson
17/04/202412h59IH Market NewsUS Index Futures See Gains, Oil Prices DipNYSE:JNJJohnson and Johnson
16/04/202422h33IH Market NewsU.S. Stocks Finish Lackluster Session Narrowly MixedNYSE:JNJJohnson and Johnson
16/04/202416h46Business WireCORRECTING and REPLACING Johnson & Johnson Reports Q1 2024 ResultsNYSE:JNJJohnson and Johnson
16/04/202415h52IH Market NewsJ&J’s Q1 2024 sales rise 2.3% to $21.4 billionNYSE:JNJJohnson and Johnson
16/04/202415h09IH Market NewsDow Looks To Snap Six-Day Losing Streak As UnitedHealth SurgesNYSE:JNJJohnson and Johnson
16/04/202413h19IH Market NewsU.S. Index Futures Signal Mixed Trading, Oil Prices DipNYSE:JNJJohnson and Johnson
16/04/202413h18IH Market NewsEricsson Soars with 66% Net Profit Growth; Live Nation Under Antitrust Scrutiny in US, and More NewsNYSE:JNJJohnson and Johnson
16/04/202412h25Business WireJohnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2%NYSE:JNJJohnson and Johnson
16/04/202412h20Business WireJohnson & Johnson Reports Q1 2024 ResultsNYSE:JNJJohnson and Johnson
15/04/202422h38IH Market NewsU.S. Stocks Extend Sell-Off As Treasury Yields Surge After Retail Sales DataNYSE:JNJJohnson and Johnson
09/04/202400h06Business WireJohnson & Johnson to Participate in the 2024 RBC Capital Markets Global Healthcare ConferenceNYSE:JNJJohnson and Johnson
06/04/202405h21PR Newswire (US)CARVYKTI® is the First and Only BCMA-Targeted Treatment Approved by the U.S. FDA for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received at Least One Prior Line of TherapyNYSE:JNJJohnson and Johnson
 Showing the most relevant articles for your search:NYSE:JNJ

Dernières Valeurs Consultées

EU
MLSML
Smalto
EU
XS1392917784
ABN AMRO Bank 4.8% 18apr...
EU
ALCAP
Capelli
BOV
BRKM6Q
BRASKEM PNB
EU
BNX1B
Bnp Paribas null
EU
I130T
I130T
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés